The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 2-3, 2010, Pages 141-145

  Rahman, Tupur ^a   Taha, Ameer Y ^a   Jun Song, Byung ^a   Orr, Sarah K ^a   Liu, Zhen ^a   Chen, Chuck T ^a   Bazinet, Richard P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Arachidonic acid; Behavioural deficits; Brain; Cholesterol; Docosahexaenoic acid; Knockout; Mouse; Polyunsaturated fatty acid; Transport; Very low density lipoprotein receptor

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; POLYUNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN FUNCTION; BRAIN REGION; CEREBELLUM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; FATTY ACID ANALYSIS; FATTY ACID TRANSPORT; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACID; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CHOLESTEROL; CHROMATOGRAPHY, GAS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, UNSATURATED; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, LDL;

MUS;

EID: 77951630116     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.11.003     Document Type: Article

References (73)

1. Diau G.Y., Hsieh A.T., Sarkadi-Nagy E.A., et al. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Medicine 2005, 3:11.
2. Akbar M.F., Calderon F., Wen Z. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:10858-10863.
3. Bazan N.G. Synaptic signaling by lipids in the life and death of neurons. Molecular Neurobiology 2005, 31:219-230.
4. Rao J.S., Ertley R.N., Lee H.J., DeMar J.C., Arnold J.T., Rapoport S.I., Bazinet R.P. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Molecular Psychiatry. 2007, 12:36-46.
5. Axelrod J. Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochemical Society Transactions 1990, 18:503-507.
6. Innis S.M. Dietary (n-3) fatty acids and brain development. The Journal of Nutrition 2007, 137:855-859.
7. Kothapalli K.S., Anthony J.C., Pan B.S., Hsieh A.T., Nathanielsz P.W., Brenna J.T. Differential cerebral cortex transcriptomes of baboon neonates consuming moderate and high docosahexaenoic acid formulas. PloS One 2007, 2:e370.
8. Calon F., Lim G.P., Yang F., et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004, 43:633-645.
9. Phillis J.W., Horrocks L.A., Farooqui A.A. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Research Reviews 2006, 52:201-243.
10. Sinclair A.J., Begg D., Mathai M., Weisinger R.S. Omega 3 fatty acids and the brain: review of studies in depression. Asia Pacific Journal of Clinical Nutrition 2007, 16(Suppl 1):391-397.
11. Scott B.L., Bazan N.G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:2903-2907.
12. Lefkowitz W., Lim S.Y., Lin Y., Salem N. Where does the developing brain obtain its docosahexaenoic acid? Relative contributions of dietary alpha-linolenic acid, docosahexaenoic acid, and body stores in the developing rat. Pediatric Research 2005, 57:157-165.
13. Cunnane S.C., Francescutti V., Brenna J.T., Crawford M.A. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 2000, 35:105-111.
14. Chen C.T., Green J.T., Orr S.K., Bazinet R.P. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2008, 79:85-91.
15. Hamilton J.A., Hillard C.J., Spector A.A., Watkins P.A. Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders. Journal of Molecular Neuroscience 2007, 33:2-11.
16. M. Lagarde, N. Bernoud, N. Brossard et al., Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain, Journal of Molecular Neuroscience 16 (2001) 201-204;discussion 215-221.
17. Kamp F., Hamilton J.A. pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:11367-11370.
18. Kamp F., Zakim D., Zhang F., Noy N., Hamilton J.A. Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry 1995, 34:11928-11937.
19. Mitchell R.W., Edmundson C.L., Miller D.W., Hatch G.M. On the mechanism of oleate transport across human brain microvessel endothelial cells. Journal of Neurochemistry 2009, 110:1049-1057.
20. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Research 1992, 17:187-214.
21. Chen C.T., Liu Z., Ouellet M., Calon F., Bazinet R.P. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2009, 80:157-163.
22. M. Ouellet, V. Emond, C.T. Chen et al., Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study, Neurochemistry International. 55 (2009) 476-482.
23. Edmond J., Higa T.A., Korsak R.A., Bergner E.A., Lee W.N. Fatty acid transport and utilization for the developing brain. Journal of Neurochemistry 1998, 70:1227-1234.
24. Innis S.M., Sprecher H., Hachey D., Edmond J., Anderson R.E. Neonatal polyunsaturated fatty acid metabolism. Lipids 1999, 34:139-149.
25. Marbois B.N., Ajie H.O., Korsak R.A., Sensharma D.K., Edmond J. The origin of palmitic acid in brain of the developing rat. Lipids 1992, 27:587-592.
26. Polozova A., Gionfriddo E., Salem N. Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2006, 75:183-190.
27. Spector A.A. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. Journal of Molecular Neuroscience 2001, 16:159-165. discussion 215-121.
28. Hanaka S., Abe T., Itakura H., Matsumoto A. Gene expression related to cholesterol metabolism in mouse brain during development. Brain & Development 2000, 22:321-326.
29. Hofmann S.L., Russell D.W., Goldstein J.L., Brown M.S. mRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:6312-6316.
30. Meresse S., Delbart C., Fruchart J.C., Cecchelli R. Low-density lipoprotein receptor on endothelium of brain capillaries. Journal of Neurochemistry 1989, 53:340-345.
31. Gosselet F., Candela P., Sevin E., et al. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Research 2009, 1249:34-42.
32. Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. Journal of Molecular Neuroscience 2001, 16:181-193. discussion 215-121.
33. Chen C.T., Ma D.W.L., Kim J.H., Mount H.T.J., Bazinet R.P. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. Journal of Lipid Research 2008, 49:147-152.
34. Carter C.J. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochemistry International 2007, 50:12-38.
35. Taha A.Y., Chen C.T., Liu Z., Kim J.H., Mount H.T.J., Bazinet R.P. Brainstem concentrations of cholesterol are not influenced by genetic ablation of the low-density lipoprotein receptor. Neurochemical Research 2008, 34:311-315.
36. Dietschy J.M., Turley S.D. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. Journal of Lipid Research 2004, 45:1375-1397.
37. Jurevics H., Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. Journal of Neurochemistry 1995, 64:895-901.
38. Takahashi S., Kawarabayasi Y., Nakai T., Sakai J., Yamamoto T. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:9252-9256.
39. Wyne K.L., Pathak K., Seabra M.C., Hobbs H.H. Expression of the VLDL receptor in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 1996, 16:407-415.
40. Vancassel S., Ayicyrillicd S., Pifferi F., Morice E., Nosten-Bertrand M., Chalon S., Lavialle M. Cerebral asymmetry and behavioral lateralization in rats chronically lacking n-3 polyunsaturated fatty acids. Biological Psychiatry 2005, 58:805-811.
41. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., Herz J. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. Journal of Biological Chemistry 2002, 277:39944-39952.
42. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., Herz J. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999, 97:689-701.
43. Dietschy J.M., Turley S.D. Thematic review series: brain lipids cholesterol metabolism in the central nervous system during early development and in the mature animal. Journal of Lipid Research 2004, 45:1375-1397.
44. Kovanen P.T., Basu S.K., Goldstein J.L., Brown M.S. Low density lipoprotein receptors in bovine adrenal cortex II, low density lipoprotein binding to membranes prepared from fresh tissue. Endocrinology 1979, 104:610-616.
45. Kovanen P.T., Faust J.R., Brown M.S., Goldstein J.L. Low density lipoprotein receptors in bovine adrenal cortex I. Receptormediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured adrenocortical cells. Endocrionology 1979, 104:599-609.
46. Canadian Council on Animal Care. Guide to the Care and Use of Experimental Animals, Ottawa, 1993.
47. Rapoport.S.I. Blood-Brain Barrier in Physiology and Medicine 1976, Raven Press, New York.
48. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Human Development 1979, 3:79-83.
49. Ma K., Langenbach R., Rapoport S.I., Basselin M. Altered brain lipid composition in cyclooxygenase-2 knockout mouse. Journal of Lipid Research 2007, 48:848-854.
50. Ward G., Woods J., Reyzer M., Salem N. Artificial rearing of infant rats on milk formula deficient in n-3 essential fatty acids: a rapid method for the production of experimental n-3 deficiency. Lipids 1996, 31:71-77.
51. Lee H.J., Rao J.S., Chang L., Rapoport S.I., Bazinet R.P. Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder. Psychopharmacology 2007, 193:467-474.
52. H.J. Lee, J.S. Rao, S.I. Rapoport, R.P. Bazinet, Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism, Prostaglandins, leukotrienes, and essential fatty acids 77 (2007), 239-246.
53. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 1957, 226:497-509.
54. Adams M.L., Sullivan D.M., Smith R.L., Richter E.F. Evaluation of direct saponification method for determination of cholesterol in meats. Journal of Assocication of Official Analytical Chemists 1986, 69:844-846.
55. Bazinet R.P., Rao J.S., Chang L., Rapoport S.I., Lee H.J. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biological Psychiatry 2006, 59:401-407.
56. Levant B., Ozias M.K., Carlson S.E. Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. The Journal of Nutrition 2007, 137:130-134.
57. Kozarsky K.F., Donahee M.H., Rigotti A., Iqbal S.N., Edelman E.R., Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997, 387:414-417.
58. Bazinet R.P., Rao J.S., Chang L., Rapoport S.I., Lee H.J. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biological Psychiatry 2006, 59:401-407.
59. Bazinet R.P., Rao J.S., Chang L., Rapoport S.I., Lee H.J. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. Psychopharmacology 2005, 182:180-185.
60. Lee H.J., Rao J.S., Ertley R.N., et al. Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. Psychopharmacology 2007, 190:103-115.
61. Lee H.J., Rao J.S., Chang L., Rapoport S.I., Bazinet R.P. Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. Journal of Lipid Research 2008, 49:162-168.
62. Chang M.C., Grange E., Rabin O., et al. Lithium decreases turnover of arachidonate in several brain phospholipids. Neuroscience letters 1996, 220:171-174.
63. Contreras M.A., Chang M.C., Kirkby D., Bell J.M., Rapoport S.I. Reduced palmitate turnover in brain phospholipids of pentobarbital-anesthetized rats. Neurochemical Research 1999, 24:833-841.
64. DeMar J.C., Lee H.J., Ma K., et al. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochimica et Biophysica Acta 1761, 2006:1050-1059.
65. Golovko M.Y., Murphy E.J. Uptake and metabolism of plasma-derived erucic acid by rat brain. Journal of Lipid Research 2006, 47:1289-1297.
66. Demar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. Journal of Neurochemistry 2005, 94:1063-1076.
67. Igarashi M., DeMar J.C., Ma K., et al. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. Journal of Lipid Research 2007, 48:1150-1158.
68. Rapoport S.I., Rao J.S., Igarashi M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2007, 77:251-261.
69. DeMar J.C., Ma K., Bell J.M., Rapoport S.I. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. Journal of Neurochemistry 2004, 91:1125-1137.
70. Barr A.M., Fish K.N., Markou A. The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. Neuropharmacology 2007, 52:1114-1123.
71. Fedorova I., Salem N. Omega-3 fatty acids and rodent behavior. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2006, 75:271-289.
72. Maekawa N., Takashima M., Matsumata, et al. Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PloS One 2009, 4:e5085.
73. Bu G. Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family. Current Opinion in Lipidology 1998, 9:149-155.